Ciprofloxacin-resistant Salmonella typhi in the UK.
D000668:Ampicillin Resistance; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002701:Chloramphenicol / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D018432:Drug Resistance, Multiple; D006801:Humans; D007194:India; D007223:Infant; D012485:Salmonella typhi / Q000145:classification / Q000187:drug effects* / Q000235:genetics; D014296:Trimethoprim Resistance; D014435:Typhoid Fever / Q000188:drug therapy*; D006113:United Kingdom
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002939:Ciprofloxacin; D002701:Chloramphenicol